Brief: Igm Biosciences Inc Strategic Refocusing Activities Expected To Be Substantially Complete By June 30 2024
08/12/2023 21:11
Dec 9 (Reuters) - IGM Biosciences Inc IGMS.O :
* IGM BIOSCIENCES INC- COMPANY ESTIMATES IT WILL INCUR
APPROXIMATELY $1.9 MILLION IN EMPLOYEE-RELATED RESTRUCTURING
CHARGES
* IGM BIOSCIENCES INC - ALSO ANTICIPATES INCURRING
ADDITIONAL
CHARGES IN CONNECTION WITH SUSPENSION OF CLINICAL DEVELOPMENT
ACTIVITIES AS PART OF STRATEGIC REFOCUSING
* IGM BIOSCIENCES INC- STRATEGIC REFOCUSING ACTIVITIES ARE
EXPECTED TO BE SUBSTANTIALLY COMPLETE BY JUNE 30, 2024
* IGM BIOSCIENCES INC - STRATEGIC REFOCUSING ACTIVITIES ARE
EXPECTED TO BE SUBSTANTIALLY COMPLETE BY JUNE 30, 2024
((Reuters.Briefs@thomsonreuters.com;))
Recent news on IGM Biosciences
See all newsU.S. STOCKS ON THE MOVE-Energy stocks, Apple, Vertex
U.S. STOCKS ON THE MOVE-Snap, Solventum, GlobalFoundries
IGM Biosciences rises on buyout deal with Concentra Biosciences
Brief: Igm Biosciences Enters Into Agreement To Be Acquired By Concentra Biosciences For $1.247 In Cash Per Share Plus A Contingent Value Right
IGM Biosciences Inc reports results for the quarter ended March 31 - Earnings Summary